Abstract
Photophobia is one of the most common visual complaints stemming from mild traumatic brain injury (mTBI) and causes significant distress. Despite extensive research, the etiology of photophobia is poorly understood, and symptoms are difficult to treat. No randomized controlled trials of treatment of photophobia in patients with mTBI exist; however, tinted glasses have been tried with some success. Targeted therapies involving infusion of calcium gene-related peptide antibody may hold promise.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC) (2003) Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem.
Barnett BP, Singman EL. Vision concerns after mild traumatic brain injury. Curr Treat Options Neurol. 2015;17:329.
https://www.ninds.nih.gov/Disorders/All-Disorders/Traumatic-Brain-Injury-Information-Page
Hoffer ME, Balaban CD. Neurosensory disorders in mild traumatic brain injury. Neurosensory Disord Mild Trauma Brain Inj. 2019; https://doi.org/10.1016/C2016-0-03480-0.
Katz DI, Cohen SI, Alexander MP. Mild traumatic brain injury. Handb Clin Neurol. 2015;127C:131–56.
Press LJ. Vision rehabilitation: multidisciplinary care of the patient following brain injury. Optom – J Am Optom Assoc. 2011;82:724–5.
Iverson GL, Gaetz M, Lovell MR, Collins MW. Cumulative effects of concussion in amateur athletes. Brain Inj. 2004;18:433–43.
Magone MT, Kwon E, Shin SY. Chronic visual dysfunction after blast-induced mild traumatic brain injury. J Rehabil Res Dev. 2014;51:71–80.
Johnson VE, Stewart W, Smith DH. Axonal pathology in traumatic brain injury. Exp Neurol. 2013;246:35–43.
Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol. 2012;32:68–81.
Katz BJ, Digre KB. Diagnosis, pathophysiology, and treatment of photophobia. Surv Ophthalmol. 2016;61:466–77.
Vincent AJP, Spierings ELH, Messinger HB. A controlled study of visual symptoms and eye strain factors in chronic headache. Headache J Head Face Pain. 1989;29:523–7.
Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008;28:626–30.
Adams WH, Digre KB, Patel BCK, Anderson RL, Warner JEA, Katz BJ. The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol. 2006;142:82–7.
Bengtzen R, Woodward M, Lynn MJ, Newman NJ, Biousse V. The “sunglasses sign” predicts nonorganic visual loss in neuro-ophthalmologic practice. Neurology. 2008;70:218–21.
Waddell PA, Gronwall DMA. Sensitivity to light and sound following minor head injury. Acta Neurol Scand. 1984;69:270–6.
Bohnen N, Twijnstra A, Wijnen G, Jolles J. Tolerance for light and sound of patients with persistent post-concussional symptoms 6 months after mild head injury. J Neurol. 1991;238:443–6.
Moulton EA, Becerra L, Borsook D. An fMRI case report of photophobia: activation of the trigeminal nociceptive pathway. Pain. 2009;145:358–63.
Emoto H, Suzuki Y, Wakakura M, Horie C, Kiyosawa M, Mochizuki M, Kawasaki K, Oda K, Ishiwata K, Ishii K. Photophobia in essential blepharospasm – a positron emission tomographic study. Mov Disord. 2010;25:433–9.
Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Géraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–8.
Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA. Bright light produces Fos-positive neurons in caudal trigeminal brainstem. Neuroscience. 2009;160:858–64.
Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, Burstein R. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010;13:239–45.
Dolgonos S, Ayyala H, Evinger C. Light-induced trigeminal sensitization without central visual pathways: another mechanism for photophobia. Investig Ophthalmol Vis Sci. 2011;52:7852–8.
Albilali A, Dilli E. Photophobia: when light hurts, a review. Curr Neurol Neurosci Rep. 2018;18:4–9.
Mysona B, Dun Y, Duplantier J, Ganapathy V, Smith SB. Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc- in mouse retinal Müller glial cells. Cell Tissue Res. 2009;335:477–88.
Lew HL, Poole JH, Vanderploeg RD, Goodrich GL, Dekelboum S, Guillory SB, Sigford B, Cifu DX. Program development and defining characteristics of returning military in a VA Polytrauma Network Site. J Rehabil Res Dev. 2007;44:1027–34.
Stelmack JA, Frith T, Van Koevering D, Rinne S, Stelmack TR. Visual function in patients followed at a Veterans Affairs polytrauma network site: an electronic medical record review. Optometry. 2009;80:419–24.
Capó-Aponte JE, Urosevich TG, Temme LA, Tarbett AK, Sanghera NK. Visual dysfunctions and symptoms during the subacute stage of blast-induced mild traumatic brain injury. Mil Med. 2012;177:804–13.
Wojcik SM. Predicting mild traumatic brain injury patients at risk of persistent symptoms in the Emergency Department. Brain Inj. 2014;28:422–30.
Truong JQ, Ciuffreda KJ, Han MHE, Suchoff IB. Photosensitivity in mild traumatic brain injury (mTBI): a retrospective analysis. Brain Inj. 2014;28:1283–7.
Fimreite V, Willeford KT, Ciuffreda KJ. Effect of chromatic filters on visual performance in individuals with mild traumatic brain injury (mTBI): a pilot study. J Optom. 2016;9:231–9.
Yuhas PT, Shorter PD, McDaniel CE, Earley MJ, Hartwick ATE. Observer-perceived light aversion behaviour in photophobic subjects with traumatic brain injury. Clin Exp Optom. 2019;102:621–6.
Wu Y, Hallett M. Photophobia in neurologic disorders. Transl Neurodegener. 2017;6:1–6.
Evans RW, Seifert T, Kailasam J, Mathew NT. The use of questions to determine the presence of photophobia and phonophobia during migraine. Headache. 2008;48:395–7.
Choi JY, Oh K, Kim BJ, Chung CS, Koh SB, Park KW. Usefulness of a photophobia questionnaire in patients with migraine. Cephalalgia. 2009;29:953–9.
Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119:202–10.
Car Tinting Laws: Window Tint Laws in United States. https://www.tinting-laws.com. Accessed 3 Feb 2020.
Clark J, Hasselfeld K, Bigsby K, Divine J. Colored glasses to mitigate photophobia symptoms posttraumatic brain injury. J Athl Train. 2017;52:725–9.
Main A, Vlachonikolis I, Dowson A. The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache. 2000;40:194–9.
Wilkins AJ, Nimmo-Smith I, Slater AI, Bedocs L. Fluorescent lighting, headaches and eyestrain. Light Res Technol. 1989;21:11–8.
Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache J Head Face Pain. 1991;31:533–6.
Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JEA, McClane RW, Nandedkar SD, Langeberg WJ, Holubkov R, Katz BJ. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116:997–1001.
Peters M, Price J. The Peters/Price (see to play) vision concussion protocol: diagnosis and treatment? Optom Vis Perform. 2015;3:126–38.
Mares C, Dagher JH, Harissi-Dagher M. Narrative review of the pathophysiology of headaches and photosensitivity in mild traumatic brain injury and concussion. Can J Neurol Sci. 2019;46:14–22.
Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009;7:71.
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22:345–53.
Kaiser EA, Kuburas A, Recober A, Russo AF. Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT1B/D agonist. J Neurosci. 2012;32:15439–49.
Recober A, Kaiser EA, Kuburas A, Russo AF. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology. 2010;58:156–65.
Lebensohn JE. Photophobia: mechanism and implications. Am J Ophthalmol. 1951;34:1294–300.
Freeman MD, Nystrom A, Centeno C. Chronic whiplash and central sensitization; an evaluation of the role of a myofascial trigger points in pain modulation. J Brachial Plex Peripher Nerve Inj. 2009;4:2.
Shoari M, Katz BJ. Treatment of the photo-oculodynia syndrome with botulinum toxin A. Neuro-Ophthalmology. 2007;31:105–9.
Diener HC, Dodick DW, Aurora SK, Turkel CC, Degryse RE, Lipton RB, Silberstein SD, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–14.
Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15:90–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ahmad, M.T., Singman, E.L. (2021). Photophobia in Post-Concussive Syndrome. In: Henderson, A.D., Carey, A.R. (eds) Controversies in Neuro-Ophthalmic Management. Springer, Cham. https://doi.org/10.1007/978-3-030-74103-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-74103-7_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74102-0
Online ISBN: 978-3-030-74103-7
eBook Packages: MedicineMedicine (R0)